Showing results (501-510 of 645) with videos related to
Sort By:
Pageof 65
Journal of Mass Spectrometry : JMS|January 25, 2017
MALDI imaging mass spectrometry reveals multiple clinically relevant masses in colorectal cancer using large-scale tissue microarraysA Hinsch, M Buchholz, S Odinga, et al.Zentralblatt Fur Chirurgie|October 9, 2012
[Neuroendocrine tumours of the GI tract--data from the German NET Registry]N Begum, S Maasberg, U Plöckinger, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2004
Copy number of chromosome 17 but not HER2 amplification predicts clinical outcome of patients with pancreatic ductal adenocarcinomaNikolas H Stoecklein, Andreas M Luebke, Andreas Erbersdobler, et al.Cancers|April 23, 2022
Combined Targeting of AKT and mTOR Inhibits Tumor Formation of EpCAM+ and CD90+ Human Hepatocellular Carcinoma Cells in an Orthotopic Mouse ModelMohamed Moustafa, Katarzyna-Krystyna Dähling, Armin Günther, et al.Journal of Human Genetics|October 31, 2014
An A/C germline single-nucleotide polymorphism in the TNFAIP3 gene is associated with advanced disease stage and survival in only surgically treated esophageal cancerTarik Ghadban, Magdalena Schmidt-Yang, Magdalena Smif, et al.Neuroendocrinology|December 6, 2022
Cancer-Associated Fibroblasts Induce Proliferation and Therapeutic Resistance to Everolimus in Neuroendocrine Tumors through STAT3 ActivationTania Amin, Fabrice Viol, Jenny Krause, et al.Oncotarget|April 8, 2020
Loss of p16 and high Ki67 labeling index is associated with poor outcome in esophageal carcinomaFrank Jacobsen, Jacob Kohsar, Florian Gebauer, et al.Annals of Surgical Oncology|November 19, 2008
Strong impact of micrometastatic tumor cell load in patients with esophageal carcinomaAlexandra M Koenig, Klaus L Prenzel, Dean Bogoevski, et al.Kidney International|October 10, 2002
Impact of different modalities of continuous venovenous hemofiltration on sepsis-induced alterations in experimental pancreatitisEmre F Yekebas, Tim Strate, Sharam Zolmajd, et al.Cancer Investigation|June 18, 2021
Mesothelin is Commonly Expressed in Pancreatic Adenocarcinoma but Unrelated to Cancer AggressivenessSören Weidemann, Daniel Perez, Jakob R Izbicki, et al.Pageof 65